What March 2026 Is Telling Us About Healthcare’s Next Era
UnitedHealth Group projects its first revenue decline in a decade, forecasting 2026 revenue above $439 billion while its stock has fallen about 45% over the past year. The company filed a shelf registration to raise debt and equity, sparking concerns about financing strain amid a DOJ Medicare‑billing probe and losses in its Optum Health unit. Elevance Health faces a CMS‑initiated suspension of Medicare Advantage‑Prescription Drug enrollment for alleged risk‑adjustment violations, sending its shares down nearly 9% and prompting a senior‑leadership reshuffle. Meanwhile, AI adoption surges, with 63% of physicians now using AI tools daily, reshaping clinical workflows across the sector.
UnitedHealth at Barclays: Pricing for a New Baseline
UnitedHealth used its Barclays Healthcare Forum to lay out a cautious 2026 outlook anchored by a 10% Medicare cost trend and modest Medicaid rate gains, while flagging that 2027 should see the payoff from AI‑driven efficiency and OptumHealth margin recovery....